NCT02012959View on ClinicalTrials.gov

Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia

PHASE3TerminatedINTERVENTIONAL

Enrollment

9

Participants

Timeline

Start Date

September 22, 2015

Primary Completion Date

July 24, 2017

Study Completion Date

July 24, 2017

Conditions

Hyponatremia

Interventions

DRUG

Tolvaptan

Trial Locations (7)

10032

New York

20010

Washington D.C.

80045

Aurora

98105

Seattle

23298-0270

Richmond

00165

Rome

WC1N 3JH

London

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Syneos Health

OTHER

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY